USA

Melancholic people on the beach

News & Media

Take a closer look at what we’re doing across Teva worldwide

Press releases
Jun 19 / 2019
Teva Announces Launch of a Generic Version of Tracleer® (bosentan) Tablets in the United States
Jun 10 / 2019
Teva Pharmaceuticals USA, Inc. Expands Voluntary Nationwide Recall of Losartan Potassium to 50 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply, Inc.
May 29 / 2019
Teva to present new fremanezumab FOCUS Clinical Study Data for the first time at the 13th European Headache Federation Congress
Teva presents 17 posters and three oral presentations at EHF 2019 highlighting long-term and FOCUS Phase IIIb study data The poster presentations highlight FOCUS data in migraine patients who have failed two to four classes of prior migraine preventive medications; as well as present further clinical study data regarding the efficacy and safety results of fremanezumab through 12 months of treatment in patients with chronic and episodic migraine
May 28 / 2019
Teva Announces Launch of a Generic Version of Ranexa® (ranolazine) Extended-Release Tablets in the United States
Top Stories
Read the latest Teva news
21 Jun 2019
Celebrating Pride Month At Teva

Teva’s Pride Employee Resource (ERG) group members reflect on the role the Stonewall Uprising played in their own lives and the important mission of the ERG for fostering a culture of inclusion.

 

Let's Talk About MS

 

Let's Talk About Asthma

 

Kathleen Veit
HBA National Rising Star

Media Resources

Intended for use by media professionals; may be downloaded for non-commercial use 

Media Inquiries

Contact Teva Corporate Communications

Learn more

Media Kit

Files and resources for media use only

Download Teva Media Kit

Financial Reports

View Teva financial news on our global website

Learn more

Connect with us

Teva Social Media Guidelines

Learn more